# Safety and Efficacy Study of NH004 Films for Relief of Sialorrhea Symptoms in Parkinson's Disease Patients

> **NCT00761137** · PHASE2 · COMPLETED · sponsor: **NeuroHealing Pharmaceuticals Inc.** · enrollment: 19 (actual)

## Conditions studied

- Sialorrhea Secondary to Parkinson's Disease

## Interventions

- **DRUG:** 0.3 mg tropicamide
- **DRUG:** 1 mg tropicamide
- **DRUG:** 3 mg tropicamide
- **DRUG:** 0 mg tropicamide

## Key facts

- **NCT ID:** NCT00761137
- **Lead sponsor:** NeuroHealing Pharmaceuticals Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2015-10-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00761137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00761137, "Safety and Efficacy Study of NH004 Films for Relief of Sialorrhea Symptoms in Parkinson's Disease Patients". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00761137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*